Showing results (181-190 of 605) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|January 24, 2023
Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in GhanaEvans Otieku, Ama Pokuaa Fenny, Appiah-Korang Labi, et al.
Pharmacoeconomics - Open|July 29, 2021
gammaCore for Cluster Headaches: A NICE Medical Technologies GuidanceSusan O'Connell, Megan Dale, Helen Morgan, et al.
Pharmacoeconomics - Open|July 28, 2021
Revision of Ireland's Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity CostsJames F O'Mahony
Pharmacoeconomics - Open|March 23, 2019
Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot StudyShaji Sebastian, Jenna Roberts, John Waller, et al.
Pharmacoeconomics - Open|August 5, 2019
Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in GhanaSamuel N Frempong, Andrew J Sutton, Clare Davenport, et al.
Pharmacoeconomics - Open|April 16, 2020
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachel Houten, Janette Greenhalgh, James Mahon, et al.
Pharmacoeconomics - Open|May 26, 2018
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)Meryl Brod, Jane F Beck, Lise Højbjerre, et al.
Pharmacoeconomics - Open|May 16, 2018
Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0-9 Years with Pertussis in Catalonia (Spain)Pedro Plans-Rubió, Encarna Navas, Pere Godoy, et al.
Pharmacoeconomics - Open|April 7, 2018
Health-Related Quality of Life in Patients Treated with Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis in SingaporeF Yang, N Luo, T Lau, et al.
Pharmacoeconomics - Open|April 7, 2018
Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database AnalysisBernard Charbonnel, Dominique Simon, Jean Dallongeville, et al.
Pageof 61